Under the terms of the collaboration, Iktos will apply its generative AI and AI-orchestrated robotics platform to design, ...

Cancer drug developer Aktis Oncology said on Wednesday it was targeting a valuation of up to $945.4 million in its upsized ...

The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...

Boston-based Aktis Oncology has filed to go public in the U.S., according to multiple news reports. The company has operations in Durham.

The one-and-a-half-day symposium will provide an overview of recent advances in the treatment of solid tumors with novel ...

Jazz Pharmaceuticals plc looks very undervalued at 2.4x sales as oncology catalysts (Ziihera, Zepzelca, Epidiolex) drive ...

The American Society for Radiation Oncology (ASTRO) announced today that it rebranded its research foundation, formerly the ...

The dyad model fosters collaboration between academic specialists and community oncologists, ensuring seamless patient care ...

First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s ...

On August 8, 2025, the FDA granted accelerated approval to zongertinib for adult patients with unresectable or metastatic ...

In the same week that Servier announced its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has ...

Franciscan Health Oncology & Hematology Specialists are welcoming a new board certified nurse practitioner to their team.